🇺🇸 FDA
Patent

US 10988537

Antibodies comprising chimeric constant domains

granted A61PA61P43/00

Quick answer

US patent 10988537 (Antibodies comprising chimeric constant domains) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Apr 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P43/00